Internal Medicine, Critical Care Medicine · Stanford, CA
NPI
1063853109
Since 2013
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
5
Medicare group memberships
Hospitals
4
Hospital affiliations
300 Pasteur Dr
Stanford, CA, 94305
Phone (650) 723-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
469 services
Medicare patients, 2024
145
Average age 71
Drug cost, 2024
$3.0M
539 prescriptions
Company payments, 2025
$47K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roberto J Bernardo was code 99291 (critical care e&m), 183 times for 84 patients. In total Roberto J Bernardo billed 469 services in 24 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 183 | 84 | $150.46 | $28K |
| 99233 Hospital E&M - Subsequent | Facility | 100 | 19 | $86.46 | $8,646 |
| 99222 Hospital E&M - Initial | Facility | 35 | 29 | $95.76 | $3,351 |
| 99292 Critical Care E&M | Facility | 29 | 22 | $78.00 | $2,262 |
| 93451 Percutaneous Transcatheterization | Facility | 18 | 18 | $91.66 | $1,650 |
| 76937 Ultrasound - Nonspecific | Facility | 17 | 17 | $10.11 | $172 |
| 99152 Anesthesia | Facility | 16 | 16 | $8.26 | $132 |
By year: 2022 $62K for 524 services; 2023 $46K for 405 services; 2024 $49K for 469 services.
Medicare prescription drug claims, 2024
In 2024, the drug Roberto J Bernardo prescribed most often to Medicare patients was Orenitram Er (Treprostinil Diolamine), with 75 prescriptions and refills. In total Roberto J Bernardo wrote 539 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Orenitram Er Treprostinil Diolamine | 75 | 75 | Under 11 | $529K |
| Winrevair Sotatercept-Csrk | 65 | 65 | 11 | $1.2M |
| Jardiance Empagliflozin | 55 | 88 | 15 | $52K |
| Opsumit Macitentan | 54 | 54 | Under 11 | $692K |
| Spironolactone Generic | 39 | 81 | 12 | $520 |
| Sildenafil Citrate Generic | 38 | 48 | Under 11 | $3,553 |
| Adempas Riociguat | 23 | 23 | Under 11 | $316K |
| Torsemide Generic | 15 | 31 | Under 11 | $393 |
| Carvedilol Generic | 15 | 19 | Under 11 | $192 |
| Ozempic Semaglutide | 14 | 19 | Under 11 | $16K |
| Potassium Chloride Generic | 14 | 29 | Under 11 | $296 |
| Furosemide Generic | 11 | 21 | Under 11 | $52.79 |
| Gabapentin Generic | 11 | 15 | Under 11 | $198 |
Brand drugs: 307 claims; generic drugs: 232 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roberto J Bernardo $47K ($47K in general payments such as food, travel and fees) from 3 companies. The largest payer was Merck Sharp & Dohme LLC with $45K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.